BlackRock Health Sciences Term Trust (NYSE:BMEZ) Short Interest Update

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was the recipient of a significant increase in short interest in January. As of January 15th, there was short interest totaling 126,819 shares, an increase of 696.9% from the December 31st total of 15,915 shares. Based on an average daily volume of 321,506 shares, the short-interest ratio is presently 0.4 days. Based on an average daily volume of 321,506 shares, the short-interest ratio is presently 0.4 days.

BlackRock Health Sciences Term Trust Stock Performance

Shares of NYSE BMEZ traded down $0.06 during mid-day trading on Thursday, reaching $15.19. The company had a trading volume of 294,089 shares, compared to its average volume of 365,736. The company has a 50-day moving average price of $15.28 and a two-hundred day moving average price of $14.74. BlackRock Health Sciences Term Trust has a 1-year low of $12.58 and a 1-year high of $16.75.

BlackRock Health Sciences Term Trust Announces Dividend

The company also recently declared a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Friday, March 13th will be issued a dividend of $0.11 per share. The ex-dividend date is Friday, March 13th. This represents a c) dividend on an annualized basis and a dividend yield of 8.7%.

Insiders Place Their Bets

In other BlackRock Health Sciences Term Trust news, Director Robert W. Fairbairn sold 10,294 shares of the stock in a transaction on Thursday, December 18th. The stock was sold at an average price of $14.98, for a total transaction of $154,204.12. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. CWM LLC raised its stake in BlackRock Health Sciences Term Trust by 25.6% during the 4th quarter. CWM LLC now owns 3,336 shares of the company’s stock valued at $50,000 after purchasing an additional 680 shares during the period. Chapin Davis Inc. raised its position in BlackRock Health Sciences Term Trust by 3.2% during the third quarter. Chapin Davis Inc. now owns 27,605 shares of the company’s stock valued at $398,000 after buying an additional 849 shares during the period. Private Advisor Group LLC grew its stake in BlackRock Health Sciences Term Trust by 3.5% during the 3rd quarter. Private Advisor Group LLC now owns 28,039 shares of the company’s stock valued at $404,000 after acquiring an additional 940 shares in the last quarter. Truist Financial Corp increased its holdings in shares of BlackRock Health Sciences Term Trust by 5.9% in the 2nd quarter. Truist Financial Corp now owns 19,645 shares of the company’s stock valued at $280,000 after purchasing an additional 1,093 shares during the period. Finally, Brown Lisle Cummings Inc. increased its stake in BlackRock Health Sciences Term Trust by 3.4% in the 3rd quarter. Brown Lisle Cummings Inc. now owns 46,666 shares of the company’s stock valued at $673,000 after buying an additional 1,554 shares during the period.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.